Washington, DC (September 27, 2012) — Most Canadians view financial incentives for deceased kidney donation to be acceptable, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN). Nearly half of the general public in Canada also find it acceptable for living kidney donation. Studies are now needed to determine whether acceptability of financial incentives translates to more available organs to patients in critical need of a transplant.
Kidney transplantation is the best treatment for patients with kidney failure. Unfortunately, there's a shortage of kidneys available to those in need of a transplant, and donation rates from both living and deceased donors have remained relatively unchanged over the last decade.
Lianne Barnieh, PhD, Braden Manns, MD (University of Calgary, in Canada) and their colleagues looked to see whether financial incentives to increase donation are acceptable and whether they would change individuals' willingness to consider donation. To accomplish this, they administered a questionnaire in the fall of 2011 to 2,004 members of the Canadian public, 339 health professionals, and 268 people with or affected by kidney disease.
Among the major findings:
The authors also examined people's differences in opinion based on household income. "We did not find evidence that those with lower income would be more likely to donate for financial gain. Though it is not possible to determine through a questionnaire whether a system of financial incentives would exploit those with lower income, the results in our questionnaire did not show any evidence of this," said Dr. Barnieh.
Future research should examine whether financial incentives might increase donations from deceased and living kidney donors.
Study co-authors include Scott Klarenbach, MD, John Gill, MD, and Tim Caulfield, LLM.
Disclosures: The authors reported no financial disclosures
The article, entitled "Attitudes Toward Strategies to Increase Organ Donation: Views of the General Public and Health Professionals," will appear online at http://cjasn.asnjournals.org/ on September 27, 2012, doi: 10.2215/CJN.04100412.
The content of this article does not reflect the views or opinions of The American Society of Nephrology (ASN). Responsibility for the information and views expressed therein lies entirely with the author(s). ASN does not offer medical advice. All content in ASN publications is for informational purposes only, and is not intended to cover all possible uses, directions, precautions, drug interactions, or adverse effects. This content should not be used during a medical emergency or for the diagnosis or treatment of any medical condition. Please consult your doctor or other qualified health care provider if you have any questions about a medical condition, or before taking any drug, changing your diet or commencing or discontinuing any course of treatment. Do not ignore or delay obtaining professional medical advice because of information accessed through ASN. Call 911 or your doctor for all medical emergencies.
Founded in 1966, and with more than 13,500 members, the American Society of Nephrology (ASN) leads the fight against kidney disease by educating health professionals, sharing new knowledge, advancing research, and advocating the highest quality care for patients.
AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.